Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Fortress Biotech, Inc. (FBIO) had Cash Flow from Financial Activities of $-27.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$16.04M |
|
$108.36M |
|
$6.22M |
|
$9.82M |
|
$23.78M |
|
$-7.74M |
|
$150.03M |
|
$142.29M |
|
$142.29M |
|
$137.16M |
|
$137.16M |
|
$137.16M |
|
$137.16M |
|
$-7.74M |
|
$-4.58M |
|
31.54M |
|
38.41M |
|
$3.44 |
|
$2.82 |
|
| Balance Sheet Financials | |
$295.48M |
|
$2.43M |
|
$61.39M |
|
$356.87M |
|
$103.39M |
|
$36.88M |
|
$51.11M |
|
$154.50M |
|
$202.37M |
|
$175.90M |
|
$202.37M |
|
33186.67B |
|
| Cash Flow Statement Financials | |
$203.85M |
|
-- |
|
|
Cash Flow from Financial Activities |
$-27.39M |
$80.60M |
|
$257.06M |
|
$176.46M |
|
$1.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
0.15 |
|
0.19 |
|
61.23% |
|
-48.25% |
|
-48.25% |
|
-- |
|
887.23% |
|
675.68% |
|
$203.85M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
0.67 |
|
0.63 |
|
143.14 |
|
67.78% |
|
77.98% |
|
38.43% |
|
57.33% |
|
$0.00 |
|
$5.31 |
|
$5.31 |
|